Global Single Domain Antibody Platforms 麻豆原创 Research Report 2023

Publication ID:

PB502233883

Publication Date:

February 17, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Single Domain Antibody Platforms market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Single Domain Antibody Platforms is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Single Domain Antibody Platforms is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Single Domain Antibody Platforms in Diagnostic Laboratories is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Single Domain Antibody Platforms include Creative BioLabs A, Synbio Technologies, ProSci Incorporated, BioCat GmbH, Antibody Design Labs, GenScript, Oak BioSciences Inc, Rockland Immunochemicals Inc and Hybrigenics Services, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Single Domain Antibody Platforms, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Domain Antibody Platforms.
The Single Domain Antibody Platforms market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Single Domain Antibody Platforms market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Domain Antibody Platforms companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Creative BioLabs A
Synbio Technologies
ProSci Incorporated
BioCat GmbH
Antibody Design Labs
GenScript
Oak BioSciences Inc
Rockland Immunochemicals Inc
Hybrigenics Services
NeoClone Biotechnology International LLC
Kaneka Eurogentec S.A
ProteoGenix
Sanyou Biopharmaceuticals Co Ltd
Abiocenter
Segment by Type
Multi-specific Single-Domain Antibody
Bispecific Single-Domain Antibody
Multivalent Single-Domain Antibody
Mono-specific Single-Domain Antibody
Segment by Application
Diagnostic Laboratories
Clinical Laboratories
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single Domain Antibody Platforms companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Single Domain Antibody Platforms 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Multi-specific Single-Domain Antibody
1.2.3 Bispecific Single-Domain Antibody
1.2.4 Multivalent Single-Domain Antibody
1.2.5 Mono-specific Single-Domain Antibody
1.3 麻豆原创 by Application
1.3.1 Global Single Domain Antibody Platforms 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diagnostic Laboratories
1.3.3 Clinical Laboratories
1.3.4 Academic & Research Institutes
1.3.5 Pharmaceutical & Biotechnology Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single Domain Antibody Platforms 麻豆原创 Perspective (2018-2029)
2.2 Single Domain Antibody Platforms Growth Trends by Region
2.2.1 Global Single Domain Antibody Platforms 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Single Domain Antibody Platforms Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Single Domain Antibody Platforms Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Single Domain Antibody Platforms 麻豆原创 Dynamics
2.3.1 Single Domain Antibody Platforms Industry Trends
2.3.2 Single Domain Antibody Platforms 麻豆原创 Drivers
2.3.3 Single Domain Antibody Platforms 麻豆原创 Challenges
2.3.4 Single Domain Antibody Platforms 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Domain Antibody Platforms Players by Revenue
3.1.1 Global Top Single Domain Antibody Platforms Players by Revenue (2018-2023)
3.1.2 Global Single Domain Antibody Platforms Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Single Domain Antibody Platforms 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Single Domain Antibody Platforms Revenue
3.4 Global Single Domain Antibody Platforms 麻豆原创 Concentration Ratio
3.4.1 Global Single Domain Antibody Platforms 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Domain Antibody Platforms Revenue in 2022
3.5 Single Domain Antibody Platforms Key Players Head office and Area Served
3.6 Key Players Single Domain Antibody Platforms Product Solution and Service
3.7 Date of Enter into Single Domain Antibody Platforms 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Domain Antibody Platforms Breakdown Data by Type
4.1 Global Single Domain Antibody Platforms Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Single Domain Antibody Platforms Forecasted 麻豆原创 Size by Type (2024-2029)
5 Single Domain Antibody Platforms Breakdown Data by Application
5.1 Global Single Domain Antibody Platforms Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Single Domain Antibody Platforms Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Single Domain Antibody Platforms 麻豆原创 Size (2018-2029)
6.2 North America Single Domain Antibody Platforms 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Single Domain Antibody Platforms 麻豆原创 Size by Country (2018-2023)
6.4 North America Single Domain Antibody Platforms 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single Domain Antibody Platforms 麻豆原创 Size (2018-2029)
7.2 Europe Single Domain Antibody Platforms 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Single Domain Antibody Platforms 麻豆原创 Size by Country (2018-2023)
7.4 Europe Single Domain Antibody Platforms 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single Domain Antibody Platforms 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Single Domain Antibody Platforms 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Single Domain Antibody Platforms 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Single Domain Antibody Platforms 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single Domain Antibody Platforms 麻豆原创 Size (2018-2029)
9.2 Latin America Single Domain Antibody Platforms 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Single Domain Antibody Platforms 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Single Domain Antibody Platforms 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Domain Antibody Platforms 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Single Domain Antibody Platforms 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Single Domain Antibody Platforms 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Single Domain Antibody Platforms 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative BioLabs A
11.1.1 Creative BioLabs A Company Detail
11.1.2 Creative BioLabs A Business Overview
11.1.3 Creative BioLabs A Single Domain Antibody Platforms Introduction
11.1.4 Creative BioLabs A Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.1.5 Creative BioLabs A Recent Development
11.2 Synbio Technologies
11.2.1 Synbio Technologies Company Detail
11.2.2 Synbio Technologies Business Overview
11.2.3 Synbio Technologies Single Domain Antibody Platforms Introduction
11.2.4 Synbio Technologies Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.2.5 Synbio Technologies Recent Development
11.3 ProSci Incorporated
11.3.1 ProSci Incorporated Company Detail
11.3.2 ProSci Incorporated Business Overview
11.3.3 ProSci Incorporated Single Domain Antibody Platforms Introduction
11.3.4 ProSci Incorporated Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.3.5 ProSci Incorporated Recent Development
11.4 BioCat GmbH
11.4.1 BioCat GmbH Company Detail
11.4.2 BioCat GmbH Business Overview
11.4.3 BioCat GmbH Single Domain Antibody Platforms Introduction
11.4.4 BioCat GmbH Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.4.5 BioCat GmbH Recent Development
11.5 Antibody Design Labs
11.5.1 Antibody Design Labs Company Detail
11.5.2 Antibody Design Labs Business Overview
11.5.3 Antibody Design Labs Single Domain Antibody Platforms Introduction
11.5.4 Antibody Design Labs Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.5.5 Antibody Design Labs Recent Development
11.6 GenScript
11.6.1 GenScript Company Detail
11.6.2 GenScript Business Overview
11.6.3 GenScript Single Domain Antibody Platforms Introduction
11.6.4 GenScript Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.6.5 GenScript Recent Development
11.7 Oak BioSciences Inc
11.7.1 Oak BioSciences Inc Company Detail
11.7.2 Oak BioSciences Inc Business Overview
11.7.3 Oak BioSciences Inc Single Domain Antibody Platforms Introduction
11.7.4 Oak BioSciences Inc Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.7.5 Oak BioSciences Inc Recent Development
11.8 Rockland Immunochemicals Inc
11.8.1 Rockland Immunochemicals Inc Company Detail
11.8.2 Rockland Immunochemicals Inc Business Overview
11.8.3 Rockland Immunochemicals Inc Single Domain Antibody Platforms Introduction
11.8.4 Rockland Immunochemicals Inc Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.8.5 Rockland Immunochemicals Inc Recent Development
11.9 Hybrigenics Services
11.9.1 Hybrigenics Services Company Detail
11.9.2 Hybrigenics Services Business Overview
11.9.3 Hybrigenics Services Single Domain Antibody Platforms Introduction
11.9.4 Hybrigenics Services Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.9.5 Hybrigenics Services Recent Development
11.10 NeoClone Biotechnology International LLC
11.10.1 NeoClone Biotechnology International LLC Company Detail
11.10.2 NeoClone Biotechnology International LLC Business Overview
11.10.3 NeoClone Biotechnology International LLC Single Domain Antibody Platforms Introduction
11.10.4 NeoClone Biotechnology International LLC Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.10.5 NeoClone Biotechnology International LLC Recent Development
11.11 Kaneka Eurogentec S.A
11.11.1 Kaneka Eurogentec S.A Company Detail
11.11.2 Kaneka Eurogentec S.A Business Overview
11.11.3 Kaneka Eurogentec S.A Single Domain Antibody Platforms Introduction
11.11.4 Kaneka Eurogentec S.A Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.11.5 Kaneka Eurogentec S.A Recent Development
11.12 ProteoGenix
11.12.1 ProteoGenix Company Detail
11.12.2 ProteoGenix Business Overview
11.12.3 ProteoGenix Single Domain Antibody Platforms Introduction
11.12.4 ProteoGenix Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.12.5 ProteoGenix Recent Development
11.13 Sanyou Biopharmaceuticals Co Ltd
11.13.1 Sanyou Biopharmaceuticals Co Ltd Company Detail
11.13.2 Sanyou Biopharmaceuticals Co Ltd Business Overview
11.13.3 Sanyou Biopharmaceuticals Co Ltd Single Domain Antibody Platforms Introduction
11.13.4 Sanyou Biopharmaceuticals Co Ltd Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.13.5 Sanyou Biopharmaceuticals Co Ltd Recent Development
11.14 Abiocenter
11.14.1 Abiocenter Company Detail
11.14.2 Abiocenter Business Overview
11.14.3 Abiocenter Single Domain Antibody Platforms Introduction
11.14.4 Abiocenter Revenue in Single Domain Antibody Platforms Business (2018-2023)
11.14.5 Abiocenter Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Creative BioLabs A
Synbio Technologies
ProSci Incorporated
BioCat GmbH
Antibody Design Labs
GenScript
Oak BioSciences Inc
Rockland Immunochemicals Inc
Hybrigenics Services
NeoClone Biotechnology International LLC
Kaneka Eurogentec S.A
ProteoGenix
Sanyou Biopharmaceuticals Co Ltd
Abiocenter

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.